Using NSCLC orthotropic mouse models, p53 gene therapy enhances chemotherapy effectiveness and inhibits tumor growth by regulating pro-apoptotic signals, angiogenesis, and immune response. This evidence concerns the gene TP53 and non-small cell lung carcinoma.